Sabra Health Care (SBRA) Director Michael Foster Receives 791-Unit Award

What Happened

• Michael J. Foster, a director of Sabra Health Care REIT, received an award of 791 stock units on 2026-08-31. The units were reported as acquired at $0 (a dividend-equivalent credit) and are outstanding under the Issuer’s 2009 Performance Incentive Plan. These units will vest and become payable on the same terms as the original stock units to which they relate.

Key Details

• Transaction date: 2026-08-31; Form 4 filed: 2026-09-02 (appears timely).
• Transaction type: Award/grant (code A); reported acquisition price: $0.00.
• Units credited: 791 stock units (each stock unit equals the right to receive one share of common stock).
• Shares/units held after transaction: 7,027 unvested stock units + 47,553 vested stock units with payment deferred, plus the 791 newly credited units — total of 55,371 stock units reflecting rights to 55,371 shares.
• Footnotes: F1 = these 791 units are dividend-equivalent payments calculated based on market value at the dividend payment date and follow the vesting/payment terms of the original awards. F2 = breakdown of outstanding units (7,027 unvested; 47,553 vested but payment deferred).
• No sale or purchase for cash was reported — this is a non-cash award, not a market purchase or sale.

Context

• Dividend-equivalent stock units are a form of deferred compensation and do not necessarily indicate a buy/sell signal; they increase the insider’s potential future share payout subject to vesting/payment rules.
• Because the acquisition price is reported as $0, the immediate cash value is not shown on the Form 4; actual value will depend on Sabra’s common stock market price when units are paid.